Chemoinformaics analysis of 1,3-Pentadiene, 3-methyl-
| Molecular Weight | 82.146 | nRot | 1 |
| Heavy Atom Molecular Weight | 72.066 | nRig | 2 |
| Exact Molecular Weight | 82.0782 | nRing | 0 |
| Solubility: LogS | -2.274 | nHRing | 0 |
| Solubility: LogP | 2.191 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 16.6879 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.425 |
| Synth | 3.329 |
| Natural Product Likeliness | 2.547 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.011 |
| HIA | 0.003 |
| CACO-2 | -4.194 |
| MDCK | 0.0000245 |
| BBB | 0.958 |
| PPB | 0.538314 |
| VDSS | 1.686 |
| FU | 0.568489 |
| CYP1A2-inh | 0.463 |
| CYP1A2-sub | 0.857 |
| CYP2c19-inh | 0.091 |
| CYP2c19-sub | 0.906 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.637 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.28 |
| CL | 8.896 |
| T12 | 0.845 |
| hERG | 0.013 |
| Ames | 0.011 |
| ROA | 0.287 |
| SkinSen | 0.582 |
| Carcinogencity | 0.804 |
| EI | 0.993 |
| Respiratory | 0.929 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.948376 |